当前位置:首页 - 行情中心 - 津荣天宇(300988) - 财务分析 - 利润表

津荣天宇

(300988)

  

流通市值:23.32亿  总市值:30.70亿
流通股本:1.07亿   总股本:1.40亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入451,303,304.921,839,343,965.971,353,096,682.93857,693,949.13
营业收入451,303,304.921,839,343,965.971,353,096,682.93857,693,949.13
二、营业总成本404,342,3831,685,299,090.461,243,282,887.32792,517,054.16
营业成本357,833,000.491,470,699,888.881,068,814,390.25678,235,405.93
税金及附加3,827,808.128,018,883.076,855,557.274,375,493.93
销售费用3,585,511.7221,610,602.3320,021,304.9513,539,910.99
管理费用20,921,003.7294,952,985.3577,341,009.8250,496,361.05
研发费用14,678,230.1578,869,379.561,031,948.7140,119,085.16
财务费用3,496,828.811,147,351.339,218,676.325,750,797.11
其中:利息费用-15,883,534.03-7,673,034.51
其中:利息收入-2,376,396.1-1,510,345.84
加:公允价值变动收益--14,794.5233,698.63
加:投资收益-2,745,099.7-20,148,440.81-669,508.24-863,723.29
资产处置收益72,246.04-3,943,664.16-100,033.68-
资产减值损失(新)-8,771,215.51-40,290,153.03-40,577,917.67-31,905,624.91
信用减值损失(新)776,480.17-25,094,437.36-3,855,578.95-1,584,164.86
其他收益1,033,777.7611,665,542.486,448,722.882,722,064.02
营业利润平衡项目0000
四、营业利润37,327,110.6876,233,722.6371,074,274.4733,579,144.56
加:营业外收入26,687.327,956,612.29311,385.49427,341.42
减:营业外支出439,444.451,804,228.781,196,909.48620,651.02
利润总额平衡项目0000
五、利润总额36,914,353.5582,386,106.1470,188,750.4833,385,834.96
减:所得税费用9,230,720.1626,411,465.7125,005,387.3913,875,572.61
六、净利润27,683,633.3955,974,640.4345,183,363.0919,510,262.35
持续经营净利润27,683,633.3955,974,640.4345,183,363.0919,510,262.35
归属于母公司股东的净利润28,536,418.8875,843,121.1260,838,378.8730,855,212.06
少数股东损益-852,785.49-19,868,480.69-15,655,015.78-11,344,949.71
(一)基本每股收益0.20.540.430.22
(二)稀释每股收益0.20.540.430.22
八、其他综合收益275,493.33-4,077,806.3420,575.49-4,471,632.32
归属于母公司股东的其他综合收益275,507.36-4,077,806.342,009.19-4,427,653.6
九、综合收益总额27,959,126.7251,896,834.0945,203,938.5815,038,630.03
归属于母公司股东的综合收益总额28,811,926.2471,765,314.7860,840,388.0626,427,558.46
归属于少数股东的综合收益总额-852,799.52-19,868,480.69-15,636,449.48-11,388,928.43
公告日期2025-04-282025-04-222024-10-292024-08-29
审计意见(境内)标准无保留意见
TOP↑